---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-257638"
form_type: "8-K"
ticker: "ATER"
cik: "0001757715"
company_name: "Aterian, Inc."
filed_at: "2022-10-04T23:59:59+00:00"
generated_at: "2026-06-23T05:38:30.918942+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aterian prelim Q3 rev $63-67M, expects $24-29M goodwill impairment, closes $20M direct offering

## Summary
- Preliminary Q3 net revenue $63M-$67M; net loss expected due to operating loss and $24M-$29M non-cash goodwill impairment.
- Goodwill impairment charge $24M-$29M due to stock price decline and reduced market cap; previous similar charge $29M in Q1 2022.
- Closed registered direct offering of 10.64M shares + warrants for net ~$19.9M; priced at $1.90/unit for investors, $2.10 for insiders.
- Resuming M&A strategy; intends to acquire a health & wellness brand, expected to be accretive without additional headcount.
- Insider participation: CEO Yaniv Sarig, CFO Arturo Rodriguez, CLO Joe Risico, CTO Roi Zahut purchased units at $2.10 each.

## SEC filing metadata
- accession: 0001193125-22-257638
- form_type: 8-K
- ticker: ATER
- cik: 0001757715
- company_name: Aterian, Inc.
- filed_at: 2022-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 2.06, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757715/000119312522257638/0001193125-22-257638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757715/000119312522257638/d254751d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-257638
- JSON: https://secwatch.observer/filing/0001193125-22-257638.json
- Plain text: https://secwatch.observer/filing/0001193125-22-257638.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.